Advances in the epidemiology, prevention, and treatment of osteoporosis and fracturesSEEMAN, Ego.The American journal of medicine. 1997, Vol 103, Num 2A, issn 0002-9343, 95 p.Conference Proceedings

Osteoporosis : Trials and tribulations. DiscussionSEEMAN, E; BLACK, D; COOPER, C et al.The American journal of medicine. 1997, Vol 103, Num 2A, pp 74S-89S, issn 0002-9343Conference Paper

Vertebral fractures associated with osteoporosis : Patient management. DiscussionTAMAYO-OROZCO, J; ARZAC-PALUMBO, P; KARPF, D. B et al.The American journal of medicine. 1997, Vol 103, Num 2A, pp 44S-50S, issn 0002-9343Conference Paper

Clinical outcomes and treatment of hip fractures. DiscussionLYONS, A. R; KARPF, D. B; LIPS, P et al.The American journal of medicine. 1997, Vol 103, Num 2A, pp 51S-64S, issn 0002-9343Conference Paper

2C or not 2C?GUIVARCH, Céline; HALLEGATTE, Stéphane.Global environmental change. 2013, Vol 23, Num 1, pp 179-192, issn 0959-3780, 14 p.Article

The socioeconomic burden of fractures : Today and in the 21st century. DiscussionJOHNELL, O; COOPER, C; CUMMINGS, S et al.JOHNELL, O; The American journal of medicine. 1997, Vol 103, Num 2A, pp 20S-26S, issn 0002-9343Conference Paper

Clinical consequences of vertebral fractures. DiscussionROSS, P. D; LYONS, A; COOPER, C et al.The American journal of medicine. 1997, Vol 103, Num 2A, pp 30S-43S, issn 0002-9343Conference Paper

The crippling consequences of fractures and their impact on quality of life. DiscussionCOOPER, C; CUMMINGS, S; LYONS, A et al.The American journal of medicine. 1997, Vol 103, Num 2A, pp 12S-19S, issn 0002-9343Conference Paper

Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatmentOLSZYNSKI, Wojciech P; DAVISON, K. Shawn; MILLER, Paul D et al.Clinical therapeutics. 2004, Vol 26, Num 1, pp 15-28, issn 0149-2918, 14 p.Article

Epidemiology, etiology, and diagnosis of osteoporosisLANE, Nancy E.American journal of obstetrics and gynecology. 2006, Vol 194, Num 2, issn 0002-9378, S3-S11, SUPArticle

The epidemiology of osteoporosis and fractures in geriatric medicineWEHREN, Lois E.Clinics in geriatric medicine. 2003, Vol 19, Num 2, issn 0749-0690, v, 245-258 [14 p.]Article

Study of a model system for asymmetric induction in [2C+2C] photoannelation reactionsBRUNEEL, K; DE KEUKELEIRE, D; VANDEWALLE, M et al.Journal of the Chemical Society. Perkin transactions. I. 1984, Num 8, pp 1697-1700, issn 0300-922XArticle

Lot 2C. Le viaduc de Mornas = Section 2C. The Mornas viaductVALLEE, P; ROUJON, M; SAYN, P et al.Travaux (Paris). 1998, Num 742, pp 61-66, issn 0041-1906Article

Traitement de l'ostéoporose et prévention des fractures = Osteoporosis treatment and fracture preventionMARCELLI, Christian.Concours médical (Paris). 2002, Vol 124, Num 28, pp 1817-1821, issn 0010-5309, 5 p.Article

Risedronate for the prevention of fractures in postmenopausal osteoporosisSICKELS, Jennifer M; NIP, Chi-Sing.The Annals of pharmacotherapy. 2002, Vol 36, Num 4, pp 664-670, issn 1060-0280Article

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal womenKANIS, J. A; BORGSTROM, F; JOHNELL, O et al.Osteoporosis international. 2004, Vol 15, Num 11, pp 862-871, issn 0937-941X, 10 p.Article

BIS-TRIFLUORMETHYL-SULFIN, (CF₃)₂C=SO = BIS-TRIFLUOROMETHYL-SULFINES (CF₃)₂C=SOELSAESSER A; SUNDERMEYER W.1983; TETRAHEDRON LETTERS; ISSN 0040-4039; GBR; DA. 1983; VOL. 24; NO 21; PP. 2141-2142; BIBL. 6 REF.Article

THE DAT-2C SYSTEM.MATSUMOTO T; TAKASHIMA H.1977; JAP. TELECOMMUNIC. REV.; JAP.; DA. 1977; VOL. 19; NO 2; PP. 131-139; ABS. FR. ESP.; BIBL. 2 REF.Article

Can we prevent fractures ?O'NEILL, T; PAPAPOULOS, S.Baillière's clinical rheumatology. 1997, Vol 11, Num 3, pp 565-582, issn 0950-3579Article

Genetic studies of the poliovirus 2C protein, an NTPase : a plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerizationTOLSKAYA, E. A; ROMANOVA, L. I; KOLESNIKOVA, M. S et al.Journal of molecular biology. 1994, Vol 236, Num 5, pp 1310-1323, issn 0022-2836Article

How to prevent fractures in the individual with osteoporosisJAVAID, M. K; COOPER, C.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 3, pp 497-515, issn 1521-6942Article

osteoporosis: Medical prevention and treatmentLANE, J. M.Spine (Philadelphia, PA. 1976). 1997, Vol 22, Num 24, pp 32S-37S, issn 0362-2436, SUPArticle

Canine parvovirus—A review of epidemiological and diagnostic aspects, with emphasis on type 2cDECARO, Nicola; BUONAVOGLIA, Canio.Veterinary microbiology (Amsterdam). 2012, Vol 155, Num 1, pp 1-12, issn 0378-1135, 12 p.Article

Distrofia muscular de cinturas 2C: valoración y tratamiento rehabilitador en 11 casos = Limb-girdle muscular dystrophy 2C: Assessment and rehabilitation treatment in ii casesFLORES CALVETE, J; RODRIGUEZ MACIA, A; MUNOZ MATEO, J et al.Rehabilitación (Madrid). 2000, Vol 34, Num 2, pp 184-188, issn 0048-7120Article

Flexor tendon repair in zone 2CTANG, J. B.Journal of hand surgery. British volume. 1994, Vol 19, Num 1, pp 72-75, issn 0266-7681Article